Objectives: to map evidence on undergraduate students' mental health globally during the COVID-19 pandemic.
Methods: a scoping review, in which PRISMA-ScR was used.
Results: twenty-six articles were included, from which data were collected on the characteristics of articles, participants involved, and results.
Purpose Of Review: Chronic pain affects millions worldwide, reducing quality of life and posing a major healthcare challenge. This review aims to explore advancements in neurosurgical interventions for managing chronic pain, focusing on the latest neuromodulation techniques, and addressing how these innovations may offer alternative solutions for these patients.
Recent Findings: We reviewed advances in high-frequency spinal cord stimulation, dorsal root ganglion stimulation, and closed-loop neuromodulation systems, which optimize precision in pain control and reduce adverse effects.
The intraperitoneal injection (ip) of N-methyl-D-aspartate (NMDA) receptor antagonist dizocilpine, MK-801, blocks sodium appetite sensitization in rats. Therefore, NMDA receptors seem important for ingestive behavioral adaptations to episodic or chronic periods of dehydration and salt depletion. Orofacial somatic motor responses to intraoral infusion of salt, in a salt taste reactivity test, can be an index of salt palatability.
View Article and Find Full Text PDFThe present study was designed to translate the Francis Burnout Inventory Revised into Portuguese and to test this translation among a snowball sample of 266 Catholic priests serving in Portugal (91% diocesan). The data demonstrated: good internal consistency reliability for the two scales proposed by this instrument (negative affect, α = .89 and positive affect, α = .
View Article and Find Full Text PDFBraz J Otorhinolaryngol
February 2025
Objective: To evaluate outcomes of locoregionally advanced patients with Head and Neck Squamous Cell Carcinoma (HNSCC) treated with Induction Therapy (ICT).
Methods: Toxicity, response rate, and Event-Free Survival (EFS) and Overall Survival (OS) were evaluated in patients treated with docetaxel, cisplatin, and 5-Fluorouracil (TPF) or docetaxel and Cisplatin (TP).
Results: ICT regimens did not alter response to ICT, and patients' EFS and OS.